Sales & Marketing At BIO 2024, an industry vows to reclaim its narrative At BIO2024 experts agreed that in a period where pharma is deeply unpopular, the industry must be proactive in telling its story.
News Pandemic has little impact on pharma's reputation, says repo... The pandemic has had very little positive impact on the public’s perceptions of pharma although the industry has fared much better than politicians, according to a report.
Articles UK Prix Galien awards: celebrating life-changing medicines The value that the best new innovative medicines bring to patients will be recognised at this year’s UK Prix Galien awards, to be held at the H
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face